I congratulate everyone. I am pleased that the final bill before us today retains the core drug safety and clinical trial provisions from the bill that Congressman Waxman and I introduced in March, which will improve transparency at the FDA and make drugs safer. Although I had hoped the sunset would be removed from the pediatric rule and less exclusivity given to blockbuster products under the pediatric incentive program, this bill is a historic achievement which will make drugs and medical devices safer for consumers around the world. The past several years have been marked by drug scandal after drug scandal, Vioxx, Ketek, Paxil and Avandia. These drugs have harmed families across the country and come to symbolize the urgent need for reform at the FDA.
Ed Markey: “I congratulate everyone. I am pleased that the final bill before us today retains the core drug safety and clinical…”
Editor's note · Context
Discussing drug safety legislation and the need for reform at the FDA.
Share
More from Ed Markey
Corporate consolidation is sweeping the energy sector, concentrating unprecedented market power in a shrinking number of companies and threatening to drive already-high electricity costs even higher. NextEra Energy’s proposed acquisition…
I will not give a nickel to an authoritarian who is handing over our government to billionaire and corporate interests that have raised the cost of living so high that human rights become commodities that working families cannot afford.
We cannot rely on courts alone to secure strong protections for our kids’ privacy and safety — Congress must act.
The end of Haiti TPS will separate families who wish for nothing more than safety and will hurt local communities across the nation.





